OTC Markets Group

OTC Markets Group Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

Retrieved on: 
Thursday, February 29, 2024
OTCQX, Q&A, OTC Markets Group, The Annual Report, PIN, Webcast, Annual report

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2023, after the close of the U.S. capital markets on Wednesday, March 6, 2024.

Key Points: 
  • NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2023, after the close of the U.S. capital markets on Wednesday, March 6, 2024.
  • In addition, OTC Markets Group will host a conference call and webcast on Thursday, March 7, 2024, at 8:30 a.m. Eastern Time, during which management will discuss the financial results in further detail.
  • Live call participants may also select a “Call Me” option.
  • The Annual Report, earnings release, transcript of the earnings call, and management presentation will also be available in the Investor Relations section of the OTC Markets Group website at www.otcmarkets.com/investor-relations/overview .

LeapCharger Comments on Trading Restriction, Prepares to File 211 Application With FINRA

Retrieved on: 
Wednesday, February 28, 2024
Social media, EV, OTC Markets Group, OTC, LCCN, Learning, History, FINRA

At the close of trading on February 16, 2024, OTC Markets Group, Inc. (“OTC”) placed a trading restriction on the Company’s securities.

Key Points: 
  • At the close of trading on February 16, 2024, OTC Markets Group, Inc. (“OTC”) placed a trading restriction on the Company’s securities.
  • "We are committed to resolving these issues swiftly and efficiently," stated Praveenkumar Vijayakumar, CEO of LeapCharger.
  • Upon successful completion of the 211 process with FINRA, the Company’s stock will be proprietary quote eligible, which we believe will significantly enhance investor confidence,” added Vijayakumar.
  • Additional information regarding the removal of the trading restriction by OTC and the progress of the Form 211 application will be provided by LeapCharger as such updates become available.

Rocky Mountain High Brands, Inc. Recaps Company’s OTC Quarterly Filings For 2023

Retrieved on: 
Wednesday, February 28, 2024
Net, Energy, Growth, OTC Markets Group, Drink, CBD, DNA

The Company is now current with all of its filing requirements with the OTC Markets Group, and certain internal improvements have been implemented to ensure timely filings going forward.

Key Points: 
  • The Company is now current with all of its filing requirements with the OTC Markets Group, and certain internal improvements have been implemented to ensure timely filings going forward.
  • Rocky Mountain High Brands, Inc. (RMHB) is a diversified and dynamic Company committed to making a difference by raising the quality and expectations in the beverage sector.
  • Rocky Mountain NexBev, Inc., a wholly owned subsidiary of RMHB, specializes in non-alcoholic beverages, including energy drinks, custom drinks, CBD & hemp, and other specialty drinks.
  • Some of these risks and uncertainties are identified in the Company’s filings with the OTC Markets.

United Lithium Announces the Commencement of OTCQX Trading

Retrieved on: 
Monday, February 26, 2024
Lithium, Growth, Depository Trust Company, OTC Markets Group, Rainbow, OTCQX, Frankfurt Stock Exchange, DTC, Security (finance)

VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE NEWSWIRE) -- United Lithium Corp. (“United” or the “Company") (CSE: ULTH; OTCQX: ULTHF ; FWB: 0UL ) is proud to announce that its common shares are now trading on the OTCQX® Best Market (“OTCQX”) under the symbol “ULTHF”.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE NEWSWIRE) -- United Lithium Corp. (“United” or the “Company") (CSE: ULTH; OTCQX: ULTHF ; FWB: 0UL ) is proud to announce that its common shares are now trading on the OTCQX® Best Market (“OTCQX”) under the symbol “ULTHF”.
  • OTCQX is the highest and most regulated tier of the OTC Markets Group on which approximately 12,000 U.S. and global securities trade.
  • Trading on the OTCQX will enhance the visibility and accessibility of the Company to U.S. investors.
  • Trading through DTC allows for cost-effective clearing and guaranteed settlement, simplifying and accelerating the settlement process of daily trades.

Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals

Retrieved on: 
Monday, February 26, 2024
Hospital, Roger Hawkins (drummer), Comorbidity, Bed, OTC Markets Group, CMI, Documentation, Emergency department, American College, Emergency, Patient, Retrieval, Partnership, Nursing

The company's wholly owned subsidiary, Retrieve Medical, Inc. ("Retrieve"), has signed a pivotal contract to deploy its cutting-edge software at a prominent Louisiana hospital.

Key Points: 
  • The company's wholly owned subsidiary, Retrieve Medical, Inc. ("Retrieve"), has signed a pivotal contract to deploy its cutting-edge software at a prominent Louisiana hospital.
  • The agreement marks Retrieve's continued expansion into the healthcare landscape, bolstering its portfolio with another esteemed community health system.
  • "We are pleased to broaden our reach into yet another community health system," commented Dr. Mark Rosenberg, Chairman of Retrieve and Past President of the American College of Emergency Physicians.
  • "This partnership underscores our position as the premier provider of physician documentation software for hospitals and medical systems throughout the United States.

Euro Manganese Inc. Engages North American and Australian Communications Advisors

Retrieved on: 
Wednesday, February 21, 2024
TSX Venture Exchange, E06, Marketing, EMN, OTC Markets Group, JMM, CAD, ASX, Australian Securities Exchange, Frankfurt Stock Exchange

VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to announce the appointment of North American and Australian investor relations advisors to assist the Company in raising greater awareness within the investment community.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to announce the appointment of North American and Australian investor relations advisors to assist the Company in raising greater awareness within the investment community.
  • The Company has engaged LodeRock Advisors Inc. ("LodeRock") effective February 8, 2024 as its investor relations advisor in North America.
  • Concurrently, effective February 14, 2024, the Company has appointed Jane Morgan Management Pty Ltd. ("JMM") as its investor relations advisor in Australia.
  • Neither LodeRock nor JMM are current shareholders of the Company.

WPF Holdings Announces Closing of Telehealth Company Acquisition

Retrieved on: 
Wednesday, February 21, 2024
Acquisition, FICC, Telehealth, News, Health, OTC Markets Group, Life, WPFH, Regulation, Trust, Security (finance)

MELBOURNE, FL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - WPF Holdings, Inc (OTC Pink WPFH) today announces the closing of the acquisition of Virtual Health Holdings, Inc., a telemedicine group of companies with 13 years of operations and with a new subscription model, consumer telemedicine offering under the name MyGuardianDoc.

Key Points: 
  • MELBOURNE, FL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - WPF Holdings, Inc (OTC Pink WPFH) today announces the closing of the acquisition of Virtual Health Holdings, Inc., a telemedicine group of companies with 13 years of operations and with a new subscription model, consumer telemedicine offering under the name MyGuardianDoc.
  • WPFH is working with the Depository Trust Company to facilitate the registration of the WPFH consideration shares in the respective accounts of the former CareClix Holdings, Inc. street name shareholders.
  • VHHI is the parent holding company of CareClix, Inc., CareClix Services, Inc., CareClix RPM, Inc. and MyCareClix, Inc., d/b/a MyGuardianDoc, which all operate in the telehealth medicine markets worldwide.
  • In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

PharmaTher’s Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia

Retrieved on: 
Wednesday, February 21, 2024
Research, TGA, Food, Cancer, Drug development, Growth, OTC Markets Group, GMP, Therapeutic Goods Administration, Patent, United States patent law, Infection, Development, Trial of the century, Pharmaceutical industry

In pursuit of its clinical strategy for PD-001, Sairiyo is establishing a wholly-owned subsidiary in Australia to conduct the proposed Phase 1 study and capitalize on drug development incentives in Australia.

Key Points: 
  • In pursuit of its clinical strategy for PD-001, Sairiyo is establishing a wholly-owned subsidiary in Australia to conduct the proposed Phase 1 study and capitalize on drug development incentives in Australia.
  • Sairiyo could earn a 43.5 percent rebate from the Australian Federal Government’s Research and Development tax incentive program.
  • Sairiyo has commenced working on a regulatory application to the TGA for its proposed Phase 1 study in Australia.
  • We expect to submit the regulatory package to the TGA for a proposed Phase 1 clinical study in Australia in Q2-2024.”

CIBL, Inc. Reports Preliminary (Unaudited) Fourth Quarter and Full Year 2023 Operating Results

Retrieved on: 
Friday, March 8, 2024
Networks, Internet, Mobile, Wireless, Technology, Telecommunications, OTC, MachTen, OTC Markets Group, MACT, Communication, LICT

CIBL, Inc. (“CIBL” or the “Company”; OTC Pink ®: CIBY) announces preliminary unaudited results for the quarter and year ending December 31, 2023.

Key Points: 
  • CIBL, Inc. (“CIBL” or the “Company”; OTC Pink ®: CIBY) announces preliminary unaudited results for the quarter and year ending December 31, 2023.
  • For the three months ended December 31, 2023, the New Hampshire Operations generated $481,000 in operating revenues, an 5.9% increase from the $455,000 reported for the quarter ended December 31, 2022.
  • EBITDA from the New Hampshire Operations was $138,000 in the 2023 period as compared to $113,000 in 2022.
  • On December 31, 2023, liquid investments were approximately $22.7 million or $1,794 per share, based on the 12,668 shares outstanding at year end December 31, 2023.

LICT Corporation Reports Preliminary Unaudited Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, March 4, 2024
Technology, Networks, Data Management, Telecommunications, Acquisition, Engineering, Internet, CIBL, Federal Communications Commission, AFI, OTC, MTCC, Capital expenditure, OTC Markets Group, MACT, Sale, Incumbent local exchange carrier, LICT, SHARE, Sound, DFT, Organization, Public expenditure, MachTen, ACP, Berkshire Hathaway, ILEC, State, GAMCO Investors, Data-rate units, MTC, Video game

LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports unaudited, preliminary financial results for the quarter ended December 31, 2023.

Key Points: 
  • LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports unaudited, preliminary financial results for the quarter ended December 31, 2023.
  • Regulated revenues were $11.5 million in the fourth quarter of 2023, a decline of $0.6 million versus the prior year’s fourth quarter of $12.1 million.
  • Regulated EBITDA in the fourth quarter of 2023 was $3.9 million compared to $5.1 million during the same period last year.
  • CAPITAL EXPENDITURES – For the fourth quarter of 2023, capital expenditures were $7.5 million versus $12.0 million in the fourth quarter of 2022.